ADAM17 and hepatocellular carcinoma: In this study, we integrated transcriptomic profiling, single-cell RNA sequencing (scRNA-seq), immune infiltration analysis, and molecular docking techniques to investigate the molecular mechanisms underlying AFB1-associated TACE nonresponse in HCC.